| Literature DB >> 12850334 |
Paul Watts1, Stephen J Haswell.
Abstract
To develop a new generation of drugs, pharmaceutical companies need to be able to synthesize and screen novel chemicals with enhanced speed. New technology that would enable a cost-neutral increase in the number of potential drug candidates would provide a distinct competitive advantage. The miniaturisation of chemical reactors offers many fundamental and practical advantages of relevance to the pharmaceutical industry, which is constantly searching for controllable, information-rich, high-throughput and environmentally friendly methods of producing compounds with a high degree of chemical selectivity. This article reviews the current and future applications of micro reactors that could enhance the drug discovery process.Mesh:
Substances:
Year: 2003 PMID: 12850334 DOI: 10.1016/s1359-6446(03)02732-6
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851